Université de Clermont Auvergne, CHU Clermont-Ferrand, Palliative Care Center, 63001, Clermont-Ferrand, France.
Université de Clermont Auvergne, CHU Clermont-Ferrand, ACCePPT UCA, Palliative Care Center, 63001, Clermont-Ferrand, France.
BMC Complement Med Ther. 2023 Feb 28;23(1):66. doi: 10.1186/s12906-023-03873-5.
In palliative care, the relief of discomfort is sought by an overall approach, combining prescribed medication and additional therapies, such as foot reflexology (FR). The main objective of this study was to assess the feasibility of FR in a population of inpatients in a palliative care unit (PCU).The precariousness of the patients led us to perform a feasibility study and not a cohort study from the outset. Its secondary objective was to assess the impact of an FR session on some symptoms of discomfort (anxiety, pain, troubled sleep, and psychological distress).
This is a feasibility study designed as a randomized controlled two-arm therapeutic trial. One arm tested FR, the other an active control, massage therapy (MT). The evaluators were blinded.
FR was feasible for 14 patients out of the 15 included in the FR group (95% CI [68%; 100%]). These patients were in the palliative care phase of cancer, motor neuron disease, or terminal organ failure. Concerning the symptoms of discomfort, ESAS sleep quality score was on average 3.9 (± 2.5) before a session in the FR group. It was improved to an average of 3 (± 2.3) on the day after the session (effect-size = 0.38 [0.03; 0.73]).
This study confirms the feasibility of an FR session for patients hospitalized in a PCU. It resulted in a slight improvement in sleep quality. For other discomfort symptoms such as anxiety, pain and distress, FR yielded a non-significant improvement. Significant results would have needed a larger cohort.
在姑息治疗中,通过整体方法寻求缓解不适,结合规定的药物和其他疗法,如足部反射疗法(FR)。本研究的主要目的是评估 FR 在姑息治疗病房(PCU)住院患者中的可行性。患者的脆弱性使我们从一开始就进行了可行性研究,而不是队列研究。其次要目的是评估 FR 疗程对一些不适症状(焦虑、疼痛、睡眠困扰和心理困扰)的影响。
这是一项可行性研究,设计为随机对照两臂治疗试验。一个手臂测试 FR,另一个手臂测试主动对照,按摩疗法(MT)。评估者是盲法的。
FR 在 FR 组的 15 名患者中有 14 名(95%CI[68%;100%])是可行的。这些患者处于癌症、运动神经元疾病或终末器官衰竭的姑息治疗阶段。关于不适症状,ESAS 睡眠质量评分在 FR 组治疗前平均为 3.9(±2.5)。在疗程后的第二天,它改善到平均 3(±2.3)(效应大小=0.38[0.03;0.73])。
这项研究证实了 FR 疗程在 PCU 住院患者中的可行性。它导致睡眠质量略有改善。对于其他不适症状,如焦虑、疼痛和困扰,FR 没有显著改善。需要更大的队列才能得出显著结果。